Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Anker

Showing results (181-190 of 184) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 184 results.
European Journal of Heart Failure|July 31, 2025
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomesMahir Karakas, Tim Friede, Javed Butler, et al.
European Journal of Heart Failure|May 29, 2020
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology SocietyAlexander R Lyon, Susan Dent, Susannah Stanway, et al.
ESC Heart Failure|February 4, 2025
Assessment of frailty in patients with heart failure: A new Heart Failure Frailty Score developed by Delphi consensusCristiana Vitale, Emmanuelle Berthelot, Andrew J S Coats, et al.
Faraday Discussions|December 13, 2024
Discovering structure-property correlations: general discussionAndy S Anker, Alán Aspuru-Guzik, Chiheb Ben Mahmoud, et al.
Pageof 19

Showing results (181-190 of 184) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 184 results.
European Journal of Heart Failure|July 31, 2025
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomesMahir Karakas, Tim Friede, Javed Butler, et al.
European Journal of Heart Failure|May 29, 2020
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology SocietyAlexander R Lyon, Susan Dent, Susannah Stanway, et al.
ESC Heart Failure|February 4, 2025
Assessment of frailty in patients with heart failure: A new Heart Failure Frailty Score developed by Delphi consensusCristiana Vitale, Emmanuelle Berthelot, Andrew J S Coats, et al.
Faraday Discussions|December 13, 2024
Discovering structure-property correlations: general discussionAndy S Anker, Alán Aspuru-Guzik, Chiheb Ben Mahmoud, et al.
Pageof 19